- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: N-(7-benzoyl-2,3-dihydro-1,4-benzodioxin-6-yl)-2-bromobenzamide
01.1: 21 residues within 4Å:- Chain A: T.150, I.153, V.154, S.271, V.272, L.275, T.404, V.405, I.407, G.408, L.409, V.411, Q.412, Y.417, S.418, A.419, A.422, F.426, F.429
- Ligands: 02.3, 02.6
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.272, A:L.275, A:L.275, A:Q.412, A:A.419, A:A.422, A:F.426
- Hydrogen bonds: A:Q.412
- Halogen bonds: A:T.404
01.7: 21 residues within 4Å:- Chain B: T.150, I.153, V.154, S.271, V.272, L.275, T.404, V.405, I.407, G.408, L.409, V.411, Q.412, Y.417, S.418, A.419, A.422, F.426, F.429
- Ligands: 02.8, 02.10
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:V.272, B:L.275, B:L.275, B:Q.412, B:A.419, B:A.422, B:F.426
- Halogen bonds: B:T.404
- 6 x 02: [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate
02.2: 27 residues within 4Å:- Chain A: V.388, A.396, T.453, I.454, G.457, Y.458, L.460, A.495, V.496, L.499, A.578, I.579, I.580, V.581, G.582, G.583, M.584, L.586, F.587
- Chain B: F.461, L.465, G.576, I.579, I.580
- Ligands: Y01.5, 02.6, 02.9
9 PLIP interactions:7 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:V.388, A:I.454, A:L.499, A:I.579, A:V.581, A:F.587, A:F.587, B:F.461, B:F.461
02.3: 26 residues within 4Å:- Chain A: S.149, I.153, I.174, T.175, Y.177, V.178, F.181, G.182, A.329, C.330, A.333, V.334, F.337, S.338, A.357, L.358, A.361, F.401, V.405, M.521, S.524, L.525, G.527, P.528, L.529
- Ligands: 01.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:V.178, A:A.329, A:A.333, A:V.334, A:V.334, A:F.337, A:A.357, A:A.361, A:L.525, A:P.528, A:L.529
02.6: 42 residues within 4Å:- Chain A: Q.142, T.146, L.243, F.263, A.264, T.267, A.268, S.271, I.393, A.396, G.397, M.400, F.401, L.403, T.404, C.406, I.407, Y.410, F.429, M.433, L.460, A.463, M.464, G.467, M.471, L.481, P.484, I.485, G.488, I.492, V.496, L.499, T.500, A.503, A.519, L.520, Q.523, Y.567, T.568, L.571
- Ligands: 01.1, 02.2
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:L.243, A:F.263, A:T.267, A:L.403, A:T.404, A:I.407, A:Y.410, A:Y.410, A:L.460, A:V.496, A:V.496, A:L.499, A:Y.567, A:L.571
- Hydrogen bonds: A:S.271, A:T.404, A:Q.523
02.8: 41 residues within 4Å:- Chain B: Q.142, T.146, L.243, F.263, A.264, T.267, A.268, S.271, I.393, A.396, G.397, M.400, F.401, L.403, T.404, C.406, I.407, Y.410, F.429, M.433, L.460, A.463, M.464, G.467, M.471, P.484, I.485, G.488, I.492, V.496, L.499, T.500, A.503, A.519, L.520, Q.523, Y.567, T.568, L.571
- Ligands: 01.7, 02.9
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:L.243, B:F.263, B:T.267, B:L.403, B:T.404, B:Y.410, B:Y.410, B:Y.410, B:L.460, B:V.496, B:V.496, B:L.499, B:Y.567, B:L.571
- Hydrogen bonds: B:S.271, B:T.404, B:Q.523
02.9: 33 residues within 4Å:- Chain A: F.461, L.465, G.576, I.579, I.580
- Chain B: R.384, N.385, V.388, A.396, M.400, T.453, I.454, G.457, Y.458, L.460, F.461, I.492, A.495, V.496, L.499, A.578, I.579, I.580, V.581, G.582, G.583, M.584, A.585, L.586, F.587
- Ligands: 02.2, Y01.4, 02.8
5 PLIP interactions:1 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:F.461, B:R.384, B:I.454, B:I.492, B:V.496
02.10: 27 residues within 4Å:- Chain B: S.149, I.153, I.174, T.175, Y.177, V.178, F.181, G.182, M.185, A.329, C.330, A.333, V.334, F.337, S.338, A.357, L.358, A.361, F.401, V.405, M.521, S.524, L.525, G.527, P.528, L.529
- Ligands: 01.7
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:V.178, B:A.329, B:V.334, B:V.334, B:F.337, B:F.337, B:A.357, B:A.361, B:L.525, B:P.528, B:L.529
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.4: 13 residues within 4Å:- Chain A: V.530, V.533, R.541, Y.569, L.572, W.573, G.576, A.577, I.580
- Chain B: R.450, L.586, F.587
- Ligands: 02.9
8 PLIP interactions:4 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.586, B:F.587, B:F.587, B:F.587, A:Y.569, A:L.572, A:L.572, A:A.577
Y01.5: 13 residues within 4Å:- Chain A: R.450, L.586, F.587
- Chain B: V.530, V.533, R.541, Y.569, L.572, W.573, G.576, A.577, I.580
- Ligands: 02.2
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:L.586, A:F.587, A:F.587, B:Y.569, B:W.573
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Khandelwal, N.K. et al., BRD-8000.3 bound EFPA transporter of Mycobacterium tuberculosis. To Be Published
- Release Date
- 2025-02-05
- Peptides
- Uncharacterized MFS-type transporter EfpA: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: N-(7-benzoyl-2,3-dihydro-1,4-benzodioxin-6-yl)-2-bromobenzamide
- 6 x 02: [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Khandelwal, N.K. et al., BRD-8000.3 bound EFPA transporter of Mycobacterium tuberculosis. To Be Published
- Release Date
- 2025-02-05
- Peptides
- Uncharacterized MFS-type transporter EfpA: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.